Prostate Cancer - Results from #23240

AUA 2013 - Session Highlights: Highlights from the Prostate Cancer Screening Session: Impact of the USPSTF recommendations on practice patterns, and new ways to improve detection and reduce complications of prostate needle biopsy May 14, 2013

AUA 2013 - Session Highlights: Comparison of nomograms vs. multiparametric MRI for prediction of extracapsular extension at time of radical prostatectomy May 14, 2013

Leptomeningeal metastasis from prostate cancer - Abstract May 14, 2013

125I brachytherapy for localized prostate cancer: A single institution experience - Abstract May 14, 2013

Active surveillance: Patient selection - Abstract May 14, 2013

Should bone scan be performed in Chinese prostate cancer patients at the time of diagnosis? - Abstract May 14, 2013

AUA 2013 - Session Highlights: Intermittent docetaxel therapy for metastatic prostate cancer. A new paradigm? May 14, 2013

AUA 2013 - Session Highlights: Intermittent androgen ablation for advanced prostate cancer: Pooled analysis from randomized prospective trials May 14, 2013

AUA 2013 - Session Highlights: Long-term quality-of-life data from CAPSURE for men with localized prostate cancer May 14, 2013

Intratumoral inflammation is associated with more aggressive prostate cancer - Abstract May 14, 2013

Pathological outcomes of Japanese men eligible for active surveillance after radical prostatectomy - Abstract May 14, 2013

The management of prostate cancer: A retrospective chart review in 808 French men undergoing biopsy - Abstract May 14, 2013

Bilateral nerve sparing robotic-assisted radical prostatectomy is associated with faster continence recovery but not with erectile function recovery compared with retropubic open prostatectomy: The need for accurate selection of patients - Abstract May 14, 2013

Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer - Abstract May 14, 2013

Proton beam radiation therapy for prostate cancer-Is the hype (and the cost) justified? - Abstract May 14, 2013

AUA 2013 - Session Highlights: Abiraterone shows improvement in quality of life outcomes at > 2 years of follow-up May 14, 2013

AUA 2013 - Session Highlights: Revisiting FDG-PET/CT in the primary staging of high risk prostate cancers before local therapies May 14, 2013

AUA 2013 - Session Highlights: Utility of salvage lymph node dissection in men with recurrent prostate cancer following local therapy May 14, 2013

AUA 2013 - Session Highlights: Performance of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy May 13, 2013

AUA 2013 - Session Highlights: Employing the epigenetic field effect to detect prostate cancer in biopsy-negative patients May 13, 2013

Page 1163 of 1437